Sandler Laura Lee's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Sep 15, 2026
- Accession no.
- 0000907654-26-000094
- Filed
- Sep 15, 2026, 7:11 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $86.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandler Laura LeeCIK 0002075401 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | SSaleDisposed | −906 | $95.71 | −$86,713.26 | 235,478 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.